Outcomes of Propofol or Thiopental Sodium and Oral Midazolam as an Induction Agent for Day Care Surgery
DOI:
https://doi.org/10.53350/pjmhs20221611663Abstract
Background: Acceptance of day surgery has been steadily rising for over a decade. Day surgery is essential in developing countries since it allows for quick healing and lower overall costs. Day surgeries have been on the rise in recent years. Induction agents like propofol and thiopentone are frequently utilized during outpatient procedures. This study aimed to compare Hayatabad Medical Complex Peshawar grade I and II patients undergoing day surgery, the compass reading time, hemodynamic comeback, respiratory upshots, and the postoperative resurgence of the two medications.
Objective: Oral midazolam, thiopental sodium, and propofol were all used for induction before day surgery. The goal was to determine which method was most cost-effective and resulted in the quickest recovery.
Place and Duration: Hayatabad Medical Complex, Peshawar for the duration from January 2022 to June 2022.
Methodology: A total of sixty patients were selected, practically thirty from one Hayatabad Medical Complex Peshawar. In group A, patients were given 2.0 mg/kg of propofol for compass reading, while in group B, patients were given 0.250 mg/kg of oral midazolam 30 minutes prior they were prearranged 2.50 mg/kg of thiopental sodium for induction. During the operation, doctors kept tabs on the patient's vital signs, BP, recuperation score, and ability to return home. For both groups, we calculated the typical price of induction.
Result: After 30 minutes of reverse, group A scored 8.8± 1.75, and group B scored 8.01± 1.03. Group B costs (BDT 37.88±1.37) were considerably lower than (BDT 142.00±6.00), with a P value of< 0.05.
Conclusion: For outpatient surgeries, using vocal midazolam and low- a prescribed amount of thiopental sodium orientation is more cost- effectual than propofol induction.
Keywords: Day care surgery, Oral midazolam, Thiopental sodium, Propofol.
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.